Survey: 4-out-of-5 smartphone users access retail content
RESTON, Va. — Four-out-of-every-5 smartphone users — 85.9 million people — accessed retail content on their device in July, according to a study by ComScore.
Amazon led as the top retailer with an audience of 49.6 million visitors, representing 46.6% of smartphone owners, followed by eBay with 32.6 million visitors and Apple with 17.7 million visitors. Walmart had the largest reach among traditional brick-and-mortar retailers with 16.3 million visitors, followed by Target with 10 million visitors and Best Buy with 7.2 million smartphone visitors.
"With nearly 86 million Americans now shopping on their smartphones, this pronounced shift in consumer behavior is simply too large for retailers to ignore, with the future of their business depending on how well they adapt to the new environment," ComScore SVP mobile Mark Donovan said. "The retailers who best understand how consumers are engaging in mobile shopping behaviors and design their strategies accordingly will be best positioned to capitalize on these shifting market dynamics."
FDA approves Acton asthma drug
MARLBOROUGH, Mass. – The Food and Drug Administration has approved a drug made by Acton Pharmaceuticals for asthma, the company said Thursday.
The drug maker announced the approval of Aerospan (flunisolide HFA) inhalation aerosol as a maintenance treatment for asthma in patients aged 6 and older. The drug maker plans to launch the drug in early 2013.
Asthma affects more than 24 million Americans, according to the Centers for Disease Control and Prevention, and healthcare market research firm IMS Health estimates the market for inhaled steroids to be worth $8.3 billion.
Mobile MTM developer receives NIH grant
CHICAGO – A company developing mobile medication therapy management technology got a big boost from the federal government.
Leap of Faith Technologies announced that it had received a grant worth more than $1 million from the National Cancer Institute, part of the National Institutes of Health, to develop its eMedonline software-as-service mHealth mobile-health platform for iPhone and Android devices. The company said the platform improves medication adherence, monitors outcomes and provides opportunities for drug surveillance and research data mining, saying the platform had demonstrated medication adherence levels of 98%, along with “significant” improvements in patient self-efficacy in NIH- and industry-funded clinical trials.
The company hopes to use the grant to bring its technology to the marketplace, and an industry partner will match the NIH grant to connect the platform to an electronic health record system.
Leap of Faith founder and chief science officer Barbara Rapchak said, “eMedonline represents the convergence of mobile technology, clinical and behavioral science and validated clinical outcomes in a mHealth platform that facilitates coordinated care and also supports meaningful use.”